Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | £182.9M | £173.3M | £144.4M | £217.5M | £326.8M | £266.7M |
| Research & development | −£770,000 | −£50,000 | — | — | — | — |
| Operating expenses | £157.0M | £149.9M | £135.6M | £193.1M | — | — |
| Operating income | £22.6M | £21.9M | £3.7M | −£21.7M | £72.6M | £23.9M |
| Operating margin | 12.33% | 12.66% | 2.59% | −9.98% | 22.21% | 8.96% |
| EBITDA | £25.9M | £25.1M | £7.1M | −£14.1M | £85.1M | £37.8M |
| EBITDA margin | 14.17% | 14.48% | 4.92% | −6.48% | 26.03% | 14.19% |
| Net income | £17.0M | £17.4M | −£38.1M | −£63.3M | £61.9M | £16.3M |
| Net profit margin | 9.31% | 10.06% | −26.35% | −29.11% | 18.94% | 6.12% |
| Basic EPSper basic share | £0.17 | £0.17 | £0.37 | -£0.62 | £0.60 | £0.16 |
| Diluted EPSper diluted share | £0.16 | £0.17 | £0.37 | -£0.62 | £0.59 | £0.16 |